Prevalence of dengue infection in north Indian children with acute hepatic failure

Rashmi Kumar1, Piyush Tripathi, Sanjeev Tripathi

  • 1Department of Pediatrics, Chhatrapati Shahuji Maharaj Medical University, Lucknow, India. rashmik2005@gmail.com

Annals of Hepatology
|April 1, 2008
PubMed

Insights

Dengue infection is a significant cause of acute hepatic failure (AHF) in children, identified in 18.5% of cases in this study. Further research is needed to differentiate clinical features of dengue-related AHF.

Area of Science:

  • Virology
  • Hepatology
  • Pediatrics

Background:

  • Hepatic manifestations of dengue viral infection are recognized.
  • Acute hepatic failure (AHF) can be associated with dengue infection.

Purpose of the Study:

  • To investigate the role of dengue infection in pediatric patients presenting with AHF.
  • To determine the prevalence of dengue infection among children hospitalized with AHF.

Main Methods:

  • A study was conducted in the pediatric wards of a teaching hospital in northern India.
  • Consecutive children hospitalized with AHF were enrolled over a 3-month period.
  • ELISA for dengue IgM and real-time PCR for the dengue genome were utilized for diagnosis.

Main Results:

  • Out of 27 enrolled patients, 18.5% (5/27) had definite dengue infection confirmed by PCR.
  • Thirteen patients were positive for dengue IgM.
  • No significant differences in clinical or laboratory features were found between dengue and non-dengue AHF cases.

Conclusions:

  • Dengue infection should be considered in the etiological diagnosis of AHF in this region.
  • Further studies with larger patient cohorts are recommended to identify differentiating clinical and laboratory features of dengue-associated AHF.
Abstract

Related Concept Videos

Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...